HomeProductsBioactive CompoundsAnti-Infective AgentsHSVCAS 348086-71-5
Chemical structure of CAS 348086-71-5

N-(5-(Aminosulfonyl)-4-methyl-1,3-thiazol-2-yl)-N-methyl-2-(4-(2-pyridinyl)phenyl)acetamide

CAS No.348086-71-5
MDL No.N/A
MFC18H18N4O3S2
MW402.50
InChI KeyIVZKZONQVYTCKC-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.348086-71-5
Product NameN-(5-(Aminosulfonyl)-4-methyl-1,3-thiazol-2-yl)-N-methyl-2-(4-(2-pyridinyl)phenyl)acetamide
Heavy Atom Count27Rotatable Bond Count5
Atom Stereo Count0Bond Stereo Count0
HBA6HBD1
TPSA106.250 ŲCharge0
Exact Mass402.08203Complexity1061.75
pKa7.130XLogP2.366

Related Articles

Studies related to this compound and its mechanism of action

Baseline sensitivity of HSV-1 and HSV-2 clinical isolates and defined acyclovir-resistant strains to the helicase-primase inhibitor pritelivir.

Antiviral research • Vol. 100, Issue 2 • 2013
PMID: 24021190DOI: 10.1016/j.antiviral.2013.08.024

ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2.

The Journal of antimicrobial chemotherapy • Vol. 65, Issue 8 • 2010
PMID: 20534624DOI: 10.1093/jac/dkq198

New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease.

Nature medicine • Vol. 8, Issue 4 • 2002
PMID: 11927946DOI: 10.1038/nm0402-392

Potent in vivo antiviral activity of the herpes simplex virus primase-helicase inhibitor BAY 57-1293.

Antimicrobial agents and chemotherapy • Vol. 46, Issue 6 • 2002
PMID: 12019088PMC: PMC127257DOI: 10.1128/AAC.46.6.1766-1772.2002

Documentation